TSE:IPA ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free IPA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ImmunoPrecise Antibodies alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About ImmunoPrecise AntibodiesIPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now IPA Stock News HeadlinesMarch 15, 2024 | markets.businessinsider.comBuy Rating Affirmed: ImmunoPrecise Antibodies’ Growth and Innovation Drive Positive OutlookMarch 8, 2024 | marketwatch.comImmunoPrecise Antibodies Shares Rise 15% on Development of AI ModelApril 27, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…March 7, 2024 | msn.comIPA stock rallies 30% on new AI model for drug discoveryFebruary 13, 2024 | finance.yahoo.comImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody DiscoveryDecember 19, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call TranscriptDecember 14, 2023 | finance.yahoo.comIPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*December 6, 2023 | benzinga.comImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14April 27, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…July 14, 2023 | finance.yahoo.comImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius ResearchJune 13, 2023 | finance.yahoo.comIPA’s Subsidiary BioStrand Unveils Use Case for Solving the Information Integration Dilemma (IID)April 1, 2023 | stockhouse.comImmunoPrecise's Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with AstellasMarch 18, 2023 | seekingalpha.comImmunoPrecise Antibodies Ltd. (IPA) Q3 2023 Earnings Call TranscriptMarch 16, 2023 | finance.yahoo.comIPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023February 18, 2023 | seekingalpha.comIPA ImmunoPrecise Antibodies Ltd.December 15, 2022 | finance.yahoo.comIPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023July 29, 2022 | apnews.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022December 14, 2021 | benzinga.comImmunoPrecise Antibodies Q2 Sales $4.70MSee More Headlines Receive IPA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Biological Product (Except Diagnostic) Manufacturing Sub-IndustryN/A Current SymbolTSE:IPA CUSIPN/A CIKN/A Webwww.immunoprecise.com Phone12504830308FaxN/AEmployees66Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key Competitors(EDW.V)CVE:EDW(FSN.V)CVE:FSN(FTE.V)CVE:FTE108946 (AUA.V)CVE:AUA111040 (DNI.V)CVE:DNIView All CompetitorsInsidersJennifer Lynne BathBought 4,211 shares on 3/27/2024Total: C$6,567.90 ($1.56/share)Jennifer Lynne BathBought 1,000 shares on 3/25/2024Total: C$1,538.50 ($1.54/share)Mitchell LevineBought 10,000 shares on 3/21/2024Total: C$14,256.00 ($1.43/share)Jennifer Lynne BathBought 3,000 shares on 3/21/2024Total: C$4,140.00 ($1.38/share)Ilse RoodinkBought 200 shares on 3/18/2024Total: C$285.58 ($1.43/share) IPA Stock Analysis - Frequently Asked Questions How do I buy shares of ImmunoPrecise Antibodies? Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:IPA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
